SkinDermic
Biotechnology Research • 
Paris, Île-de-France, France • 1-10 Employees
Company overview
| Headquarters | 19, Rue Chapon, Paris, Île-de-France 75003, FR |
| Website | |
| NAICS | 541714 |
| Founded | 2017 |
| Employees | 1-10 |
| Socials |
Key Contact at SkinDermic
Philippe Grange
Co-founder of SkinDermic
SkinDermic Email Formats
SkinDermic uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@skindermic.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@skindermic.com | 100% |
About SkinDermic
SkinDermic® is a drug discovery company focused on developing breakthrough and innovative small molecule drugs for the treatment of HHV8 virus linked neoplasia and inflammatory skin diseases. SkinDermic® recently completed proof of concept clinical phase in humans with its First-in-Class treatments for acne and HHV8 associated diseases (Kaposi Sarcoma and Lymphomas). Skindermic owns now a pipeline with very active and very well tolerated new drugs for HHV8 associated diseases and acne vulgaris.
SkinDermic revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
SkinDermic has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
SkinDermic has never raised funding before.
SkinDermic Tech Stack
Discover the technologies and tools that power SkinDermic's digital infrastructure, from frameworks to analytics platforms.
Web servers
Font scripts
WordPress themes
Tag managers
JavaScript libraries
Programming languages
Security
Page builders
Blogs
Analytics
UI frameworks
Databases
United States
Netherlands
United KingdomFrequently asked questions
4.8
40,000 users
